Skip to main content

Regulatory & Access Resources

Browse our regulatory & access resources to find the latest articles, blogs, brochures, and videos from our experts. See the latest content below.

Late Phase Partnerships

Find out more about PAREXEL's late phase partnerships here!

Download PDF

As they say: ‘two heads are better than one’ and taking an integrated approach to late phase partnerships can unlock the value of your product for stakeholders. Maximize drug potential through strategy, evidence and clear communication.

Partnering with an experienced CRO is particularly beneficial in late phase clinical research as commercialization and reimbursement data requirements will have been considered from the offset. By outsourcing strategy, clinical trials benefit from a range of expert minds and a committed study partner that will spearhead market access. 

An integrated approach helps: 

• Identify data needed
• Access realization
• Data generation
• Communications strategy
• Communications execution